Replies to post #318518 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

Cassava Sciences, Inc.
November 13, 2020·5 min read

SAVA
-2.94%
AUSTIN, Texas, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced the pricing of its previously announced underwritten public offering. The Company is offering 9,375,000 shares of its common stock, par value $0.001 per share, at a price to the public of $8.00 per share. In connection with the offering, the Company has also granted the underwriters a 30-day option to purchase up to an additional 1,406,250 shares of common stock offered in the public offering.

Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that it has entered into a definitive agreement with several healthcare-focused and other institutional investors for the purchase of 4,081,633 shares of its common stock, at a purchase price per share of $49.00, for gross proceeds of approximately $200.0 million, in a registered direct offering. The closing of the offering is expected to occur on or about February 12, 2021, subject to the satisfaction of customary closing conditions.

[Steady_T]

No idea how "morally superior" or "martyrs for imaginary cause" entered into the conversation.

All that is required for what I was discussing is mutual benefit. SAVA has done IPO's and other funding rounds in ways that benefit WS so WS actively supports SAVA.

AVXL has done its financing in ways that are not as beneficial to WS so WS has not been actively supporting AVXL. No conspiracy required.

Not having that active support creates opportunities for manipulation that otherwise would not exist.

[abew4me]

Yes, they most certainly did do the "Wall Street thing".

All you have to do is look at how they raised their cash.

[raja48185]

Yes, and the FDA did not go out of the way or the norm by dismissing the advisory board's one sided decision regarding Biogen's Aduhelm when it approved the drug. Also Goldman Sach's was founded to do God's work and is still doing God's work, now being even more involved as they now have a moral responsibility, after letting the world know in 2009 the secret to their success.